The property developers are collaborating on a proptech accelerator called Propell Asia that will issue grants to participating startups.
Month: June 2018
Integrate inserts Liberty Global into $23m round
The round boosted the total raised by the marketing demand orchestration platform, which is also backed by Comcast, to $57m.
Silverfort signals Singtel to close series A
Seed backer Singtel Innov8 reinvested as part of an $11.5m round that will fund further work on Silverport’s authentication technology.
Openbay taps Shell for $8m series A
Shell Ventures led the vehicular servicing marketplace’s series A round, five years after the company raised cash from GV.
BigID digs up $30m
Comcast Ventures and SAP.iO returned to back a series B round closed only five months after the cybsersecurity software provider’s series A.
Matternet catches $16m
Boeing HorizonX Ventures led the series A round, which also attracted Swiss Post and Sony Innovation Fund.
Home Depot meets Homee in $11m round
On-demand home maintenance platform Homee has closed a series A round featuring Home Depot and corporate-backed VC firm Engage.
Chao bids goodbye to Applied Ventures
Tony Chao, senior investment director and general manager of Applied Ventures has accepted a partner position at Tyche Partners.
Carisma charms investors in $53m series A
AbbVie Ventures co-led the round having done the same for the immunotherapy developer’s last round, in 2017.
Whistle Sports wins $28m
The sports media platform has now raised $93m, after raising series D funds from investors including Liberty Media and Emil Capital.
AISpeech aces latest round
Foxconn and MediaTek contributed to a $75.7m round that speech recognition technology provider AISpeech will use for hiring and product development.
NodThera notches up $37m
The drug developer, which is targeting chronic inflammation-related diseases, has raised series A cash two years after it spun out of Selvita.
Constellation points way to public markets
SR One-backed gene expression technology developer Constellation Pharmaceuticals has filed for an $86.3m initial public offering.
Allakos aligns itself with $75m IPO
Roche and Novo-backed biopharmaceutical developer Allakos has filed for a $75m initial public offering after raising more than $160m in equity funding.